[Experience of application of meronem in the treatment of severe purulent sepsis in children].
Results of antibacterial therapy with application of meropenem (meronem by firm Astra Zeneca, Great Britain) in 29 childs with severe purulent-septic state, including 5 with toxic peritonitis, in 2--with sepsis, in 3 newborn childs--with esophageal atresia and in 19--with the blood disease (nonhodgkin's lymphoma, an acute lymphoblastic or myeloblastic leucosis, reccurrent of acute lymphoblastic leucosis, nephroblastoma).
Sleptsov
V P
VP
Kirsanov
A I
AI
Usachenko
V P
VP
Ivanova
O V
OV
Stepkina
O I
OI
Belkina
Iu E
IuE
Bondarenko
I V
IV
Panasenko
V V
VV
D000293:Adolescent; D015780:Carbapenems / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D000077731:Meropenem; D012720:Severity of Illness Index; D018746:Systemic Inflammatory Response Syndrome / Q000188:drug therapy* / Q000382:microbiology; D013845:Thienamycins / Q000627:therapeutic use*
D015780:Carbapenems; D013845:Thienamycins; D000077731:Meropenem
Opyt primeneniia meronema v lechenii tiazhelogo gnoĭno-septicheskogo sostoianiia u deteĭ.